Biogen scraps two Alzheimer drug trials, wipes $18 billion from market value
CHICAGO/TOKYO (Reuters) – Biogen Inc and partner Eisai Co Ltd are ending two late-stage trials of their experimental Alzheimer’s disease…
by October Gallery
CHICAGO/TOKYO (Reuters) – Biogen Inc and partner Eisai Co Ltd are ending two late-stage trials of their experimental Alzheimer’s disease…
Subscribe to BBC News www.youtube.com/bbcnews Wendy, Keith and Christopher are three of more than 500000 people with dementia in the…